K Number
K203337
Device Name
PainTB, PainTJ
Manufacturer
Date Cleared
2022-02-11

(456 days)

Product Code
Regulation Number
890.5500
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Pain TB and Pain TJ Laser systems are indicated for adjunctive use in the temporary relief of low-back pain and wrist pain associated with Carpal Tunnel Syndrome.
Device Description
PainTB and PainTJ can be used repeatedly and uses semiconductor lasers to generate three wavelengths of light at 670nm, 830nm and 910nm. In general, this device irradiates to the pain area with a laser beam to relieve pain. It can also be controlled via a dedicated app on your smartphone, allowing you to monitor when and how much you have used it.
More Information

No
The summary does not mention AI, ML, or any related concepts like deep learning, neural networks, or image processing. The device description focuses on laser technology and app control for monitoring usage, not intelligent data analysis or decision-making.

Yes
The device is indicated for adjunctive use in the temporary relief of low-back pain and wrist pain, which addresses a medical condition, directly supporting its classification as a therapeutic device.

No
The device description and intended use state that it is for temporary pain relief, not for diagnosing medical conditions.

No

The device description explicitly states it uses "semiconductor lasers to generate three wavelengths of light" and "irradiates to the pain area with a laser beam," indicating it is a hardware device that emits light, not solely software. While it mentions a smartphone app for control and monitoring, the core therapeutic function is performed by the laser hardware.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
  • Device Function: The Pain TB and Pain TJ Laser systems are described as devices that use laser irradiation to relieve pain in the low-back and wrist. They are applied externally to the body.
  • Intended Use: The intended use is for the temporary relief of pain, not for diagnosing a disease or condition based on in vitro analysis of biological samples.
  • Device Description: The description focuses on the physical characteristics of the device (semiconductor lasers, wavelengths) and its application method (irradiating the pain area).
  • Performance Studies: The performance study described evaluates the device's effectiveness in reducing pain based on patient-reported pain levels (VAS score), not on the analysis of biological samples.

Therefore, the Pain TB and Pain TJ Laser systems fall under the category of therapeutic devices, not in vitro diagnostic devices.

N/A

Intended Use / Indications for Use

Pain TB and Pain TJ Laser systems are indicated for adjunctive use in the temporary relief of low-back pain and wrist pain associated with Carpal Tunnel Syndrome.

Product codes

NHN

Device Description

PainTB and PainTJ can be used repeatedly and uses semiconductor lasers to generate three wavelengths of light at 670nm, 830nm and 910nm. In general, this device irradiates to the pain area with a laser beam to relieve pain. It can also be controlled via a dedicated app on your smartphone, allowing you to monitor when and how much you have used it.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

low-back, wrist

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

The PainTB was evaluated in a prospective, rater blind, randomized study that compared the "Active" Laser with a "Mock" Laser. The single-center study was conducted in the South Korea. In the test, 60 adult patients of back pain whose VAS score is 4 or higher are recruited as subiects. PainTB alone test and exercise treatment combined with PainTB use and "Mock" device use are conducted, and VAS measurement has used as pain level scale.

Statistical analyses (one-way ANOVA) were performed by generally accepted statistical techniques to evaluate the differences between the VAS scores before and after treatment follow up for patients in Group B (Active Laser + exercise treatment) and Group C (Mock Laser + exercise treatment).

The statistical analyses of the data demonstrate that the difference between the two treatment groups over time is statistically significant (p-value

§ 890.5500 Infrared lamp.

(a)
Identification. An infrared lamp is a device intended for medical purposes that emits energy at infrared frequencies (approximately 700 nanometers to 50,000 nanometers) to provide topical heating.(b)
Classification. Class II (special controls). The device, when it is an infrared therapeutic heating lamp, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 890.9.

0

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

February 11, 2022

Ptech Co., Ltd. Yosung Choi CEO 35, Wondogok-gil, Poseung-eup Pyeongtaek-si, Gyeonggi-do 13449 Korea, South

Re: K203337

Trade/Device Name: PainTB, PainTJ Regulation Number: 21 CFR 890.5500 Regulation Name: Infrared lamp Regulatory Class: Class II Product Code: NHN Dated: October 13, 2020 Received: January 10, 2022

Dear Yosung Choi:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be avare that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal

1

statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Amber Ballard, PhD Assistant Director DHT5B: Division of Neuromodulation and Physical Medicine Devices OHT5: Office of Neurological and Physical Medicine Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K203337

Device Name PainTB, PainTJ

Indications for Use (Describe)

Pain TB and Pain TJ Laser systems are indicated for adjunctive use in the temporary relief of low-back pain and wrist pain associated with Carpal Tunnel Syndrome.

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

510(K) summary

The assigned 510(k) number: K203337

  1. Date Prepared: February 11, 2022

2. Application

Company Name: Ptech Co., Ltd. Address: 35, Wondogok-gil, Poseung-eup, Pyeongtaek-si, Gyeonggi-do, Republic of Korea Tel: +82-07-4140-9595 Fax: +82 504-218-7344 Email: thomasc@p-tech.co.kr

3. Submission Correspondent

Thomas Choi Ptech Co., Ltd Tel: +82-10-4051-7344 Fax: +82 504-218-7344 Email: thomasc@p-tech.co.kr

4. Proposed Device Identification

Proprietary Name: PainTB, PainTJ Model Name:PMD-PB230, PMD-PJ230 Classification name: Infrared Lamp Device Class: Class II Regulation number: 21 CFR 890.5500 Product Code: NHN

5. Predicate devices

Manufacturer: THØR International Ltd. Brand Name: THØR DDII 830CL3 FDA 510(K) number: K030226

6. Indication for use

PainTB and PainTJ Laser systems are indicated for adjunctive use in the temporary relief of low-back pain and wrist pain associated with Carpal Tunnel Syndrome.

4

7. Device description

PainTB and PainTJ can be used repeatedly and uses semiconductor lasers to generate three wavelengths of light at 670nm, 830nm and 910nm. In general, this device irradiates to the pain area with a laser beam to relieve pain. It can also be controlled via a dedicated app on your smartphone, allowing you to monitor when and how much you have used it.

Product namePainTB/PainTB
Model namePMD-PB230/ PMD-PJ230
Product CodeNHN
Regulation Number21 CFR 890.5500
Device ClassClass II
Rated power of recharging adapterInput: 100 - 240V, 50/60Hz, 0.6 - 0.3A
Output: DC5V, 1.2A
Rated power of embedded batteryDC 3.7V 2000mAh lithium polymer
Protection type and degree against electric
shockClass II and internally powered source device,
Type BF applied part
Protection against hazardous penetration of
water and particlesIP22
Operating conditionsTemperature: 10 ℃ - 40 ℃, Humidity: 30 - 85%
R.H
Atmospheric pressure: 700 - 1,060 hPa
Transport and storage conditionsTemperature: -10℃ - 50℃, Humidity: 30 -
85% R.H.,
Atmospheric pressure: 700 - 1,060 hPa
Weight of main body/recharging adapterPMD-PB230:250g, PMD-PJ230:201g
Adapter: 70g
Size of main bodyPMD-PB230: 152mm x 245mm (thickness
15mm)
PMD-PJ230:106mm x 136mm (thickness
40mm)
Laser moduleModel Name: COB-CO-1509A
Wavelength: 670nm, 830nm, 910nm
No. of laser diodes per module:
3 per wavelength, total 9
No. of modules: PMD-PB230 8, PMD-PJ230 6
Laser class: 3B
Laser operating time20/40/60 minutes

5

Packaging1 Set
Country of originRepublic of Korea

8. COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH THE PREDICATE DEVICE

The mechanism for pain treatment using Non-heating Infrared ramp has been studied for a long time, and various products have cleared FDA 510(K) and are being used as medical devices for treatment. Our product have three wavelength's diode laser(670nm, 839nm, 910nm) and they are cross irradiated so don't be overlay to another wavelength when it is working. Also, each wavelength is generally used in pain treatment, and we can easily find similar product in the market.

The following is the result of comparing our product with the similar product in clinical literatures chosen. At the technical aspect, light sources and wavelength optical power were compared. The similar product used diode Laser and its wavelength was 830nm so it is same wave length as ours. Optical power of similar product is 30mW and our 830nm is 24.1mW so it is within the acceptable range. Thus, this product and our product have technical equivalence. In addition, the application range and the effect of the product were compared at the clinical aspect. The predicate device was used at pain treatment and reduced pain so it is same as ours. Thus, this product and our product have clinical equivalence.

There is some gap in comparison with similar products because our product have 2 more wavelength laser used. Although 830nm is major and other 670nm and 910nm laser is lower power for supporting performance of the treatment, it is showing gap with predicate device.

No.Itemdevice #1Our product
1ManufacturerThor InternationalPtech Co.,Ltd.
2Model Name
510(k)#Thor DD2 830cl3
(K030226)PMD-PB230,
PMD-PJ230
(K203337)
3Laser ClassNot Publicly Available3B
4Regulation Number21 CFR 890.550021 CFR 890.5500
5Regulatory class22
6FDA
Product codeNHNNHN
7IFUThe THOR DDII 830CL3 Laser
System is a non-heating infrared
lamp and is indicated for
adjunctive use in the temporary
relief of hand and wrist pain
associated with Carpal Tunnel
SyndromePainTB and PainTJ Laser systems are indicated
for adjunctive use in the temporary relief of low-
back pain and wrist pain associated with Carpal
Tunnel Syndrome.
8CE statusCE certifiedCE certified

6

9PictureNot Publicly AvailableImage: Two medical devices
10Light sources usedDiodeDiode
11Operation modeNot Publicly Availablepulse
12Wavelengths used830nm670nm, 830nm, 910nm Cross irradiate
13Number of Diode3[PMD-PB230]
670nm: .8
830nm:8
910nm: 8
[PMD-PJ230]
670nm: .6
830nm:6
910nm: 6
14Treatment timeNot Publicly AvailableDepends on the therapist choice
15TechnicalPower supplyNot Publicly AvailableInput:AC100-240V
Output: DC 5V, 1.2A
16Average Output830nm:3X30mW[PMD-PB230]
670nm: .8x4.5mW
830nm:8x24.1mW
910nm: 8x3mW
Total 252.8mW
[PMD-PJ230]
670nm: .6x4.5mW
830nm:6x24.1mW
910nm: 6x3mW
Total 188.6mW
17Spot SizeNot Publicly Available1.7mm (Circular)
18Energy Fluency (mW/cm2, mJ/cm2))Not Publicly Available670nm: .66mW/cm2
830nm: 354mW/cm2
910nm: 44mW/cm2
19ApplicationPain Area(hand & wrist)Pain area (low back, wrist)

9. Performance standard

Our products voluntarily comply with the standards below.

General Safety standard:IEC 60601-1:2005/AMD1:2012
EMC60601-1-2:2014
Usability:IEC 60601-1-6:2010,
Home Health Care:AMD1:2013 IEC
Medical Laser Equipment:60601-1-11:2015
Safety of laser products:IEC 60601-2-22:2007 +A1:2012
Biological evaluation(Cytotoxicity):IEC 60825-1:2014
ISO 10993-5:2009

7

Biological evaluation (Skin Sensitization):ISO 10993-10:2010
Biological evaluation (Skin Irritation):ISO 10993-10:2010

10. Summary of Clinical Information

The PainTB was evaluated in a prospective, rater blind, randomized study that compared the "Active" Laser with a "Mock" Laser. The single-center study was conducted in the South Korea. In the test, 60 adult patients of back pain whose VAS score is 4 or higher are recruited as subiects. PainTB alone test and exercise treatment combined with PainTB use and "Mock" device use are conducted, and VAS measurement has used as pain level scale.

Clinical Data Analysis and Results

Statistical analyses (one-way ANOVA) were performed by generally accepted statistical techniques to evaluate the differences between the VAS scores before and after treatment follow up for patients in Group B (Active Laser + exercise treatment) and Group C (Mock Laser + exercise treatment).

The statistical analyses of the data demonstrate that the difference between the two treatment groups over time is statistically significant (p-value